A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)

Terminated

Phase 3 Results N/A

Summary of Purpose

The purpose of this study is to determine the effectiveness of abciximab in the treatment of acute ischemic stroke. Trial Stopped: Based on the data and observed benefit-risk profile, the trial's independent oversight committee recommended that enrollment not resume.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 May 2011.

1 Oct 2003 19 Nov 2003 Unavailable 1 Dec 2005 1 Jun 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available